145 related articles for article (PubMed ID: 7534292)
1. Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells.
Giasson E; Meloche S
J Biol Chem; 1995 Mar; 270(10):5225-31. PubMed ID: 7534292
[TBL] [Abstract][Full Text] [Related]
2. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
Leduc I; Haddad P; Giasson E; Meloche S
Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells.
Servant MJ; Giasson E; Meloche S
J Biol Chem; 1996 Jul; 271(27):16047-52. PubMed ID: 8663242
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy.
Sadoshima J; Izumo S
Circ Res; 1995 Dec; 77(6):1040-52. PubMed ID: 7586215
[TBL] [Abstract][Full Text] [Related]
5. Activation of p70 S6 protein kinase is necessary for angiotensin II-induced hypertrophy in neonatal rat cardiac myocytes.
Takano H; Komuro I; Zou Y; Kudoh S; Yamazaki T; Yazaki Y
FEBS Lett; 1996 Feb; 379(3):255-9. PubMed ID: 8603701
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
7. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells.
Chiu AT; Roscoe WA; McCall DE; Timmermans PB
Receptor; 1991; 1(3):133-40. PubMed ID: 1843203
[TBL] [Abstract][Full Text] [Related]
9. Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
Iouzalen L; Stepien O; Marche P
J Pharmacol Exp Ther; 1999 Apr; 289(1):181-7. PubMed ID: 10087002
[TBL] [Abstract][Full Text] [Related]
10. Activation of AT1 angiotensin receptors induces DNA synthesis in a rat intestinal epithelial (RIE-1) cell line.
Smith RD; Corps AN; Hadfield KM; Vaughan TJ; Brown KD
Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):791-800. PubMed ID: 7945204
[TBL] [Abstract][Full Text] [Related]
11. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
12. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
[TBL] [Abstract][Full Text] [Related]
13. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
[TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP-mediated inhibition of angiotensin II-induced protein synthesis is associated with suppression of tyrosine phosphorylation signaling in vascular smooth muscle cells.
Giasson E; Servant MJ; Meloche S
J Biol Chem; 1997 Oct; 272(43):26879-86. PubMed ID: 9341120
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Weber H; Taylor DS; Molloy CJ
J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells.
Leduc I; Meloche S
J Biol Chem; 1995 Mar; 270(9):4401-4. PubMed ID: 7876204
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
Watts SW; Florian JA; Monroe KM
J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts.
Schorb W; Conrad KM; Singer HA; Dostal DE; Baker KM
J Mol Cell Cardiol; 1995 May; 27(5):1151-60. PubMed ID: 7473773
[TBL] [Abstract][Full Text] [Related]
20. Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signalling system in vascular smooth muscle cells.
Ko Y; Görg A; Appenheimer M; Wieczorek AJ; Düsing R; Vetter H; Sachinidis A
Eur J Pharmacol; 1992 Oct; 227(2):215-9. PubMed ID: 1426030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
